SpringWorks Therapeutics Inc (DELISTED) (SWTX:DL)
46.99
0.00 (0.00%)
USD |
NASDAQ |
Jul 07, 16:00
SpringWorks Therapeutics EPS Diluted (Quarterly): -1.111 for March 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vigil Neuroscience Inc (DELISTED) | -0.5599 |
| Merck & Co., Inc. | 2.316 |
| Cytokinetics, Inc. | -2.552 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Catheter Precision, Inc. | -1.705 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -83.19M |
| Revenue (Quarterly) | 49.09M |
| Total Expenses (Quarterly) | 132.27M |
| Enterprise Value | 3.252B |
| Gross Profit Margin (Quarterly) | 92.81% |
| Profit Margin (Quarterly) | -169.5% |
| Earnings Yield | -7.26% |
| Normalized Earnings Yield | -7.257 |